A Phase I/II Study of Arsenic Trioxide/Bortezomib/Ascorbic Acid Combination Therapy for the Treatment of Relapsed or Refractory Multiple MyelomaJames R. Berenson, Howard Yeh, Regina A. Swift et al.|Clinical Cancer Research|2007Cited by 123
A Phase I/II Trial Evaluating the Combination of Arsenic Trioxide, Bortezomib and Ascorbic Acid for Patients with Relapsed or Refractory Multiple Myeloma.James R. Berenson, Sal Bevivino, Regina A. Swift et al.|Blood|2005Cited by 11